Prifinium Bromide (International)
Note: In some countries, this medicine may only be approved for veterinary use.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A03AB18
CAS registry number (Chemical Abstracts Service)
0004630-95-9
Chemical Formula
C22-H28-Br-N
Molecular Weight
386
Therapeutic Category
Spasmolytic agent
Chemical Name
Pyrrolidinium, 3-(diphenylmetylene)-1,1-dietyl-2-metyl-, bromide
Foreign Names
- Prifinii Bromidum (Latin)
- Prifinium bromid (German)
- Bromure de Prifinium (French)
- Bromuro de prifinio (Spanish)
Generic Names
- Prifinio bromuro (OS: DCIT)
- Prifinium Bromide (OS: JAN)
- PDB (IS)
- Pyrodifenium bromide (IS)
Brand Names
- Anespas
Sanofi-Aventis, Mexico - Fridial
Teriak, Tunisia - Fridial enfant [pediatric]
Teriak, Tunisia - Prifinial [veterinary use]
Vetoquinol, France - Prifinial Chats et Chiens nains [veterinary use]
Vetoquinol, France - Prifinial für Hunde und Katzen [veterinary use]
Vetoquinol Österreich, Austria - Prifinial N Für Hunde [veterinary use]
Vetoquinol, Switzerland - Riabal
Hikma, Lebanon; Hikma, Oman; IBI, Italy - Riabal [+ Paracetamol]
Hexpharm Jaya, Indonesia - Riabal enfant
Teriak, Tunisia
Glossary
Term | Definition |
---|---|
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.